Opportunity Information: Apply for RFA AG 23 003

The National Institutes of Health (NIH) published this discretionary funding opportunity, RFA-AG-23-003, titled "Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)." It uses the cooperative agreement mechanism (U24), which means the awardee is expected to work in close partnership with NIH staff as substantial involvement is typical for this type of funding. The overall aim is not to run a clinical trial, but to build and operate a coordinated set of resources that make it easier for the research community to work across multiple long-running studies of aging that have unusually rich, detailed measurement ("deep phenotyping") in psychological, behavioral, social, and biobehavioral domains.

At the center of the FOA is the creation of a Resource Development Network. In practical terms, this network is meant to serve as shared infrastructure that helps separate longitudinal cohorts and studies align with one another, communicate, and collaborate more efficiently. These kinds of studies often collect overlapping but not identical measures over many years, which can make cross-study comparisons and pooled analyses difficult even when the scientific questions are similar. The NIH is looking for an effort that actively supports coordination across these studies so that investigators can more readily harmonize measures, compare findings, innovate on methods, and generate insights about aging that are stronger and more generalizable than any single study could deliver alone.

The opportunity is framed around studies of aging that are "deeply phenotyped" and "longitudinal," emphasizing repeated measurement over time and broad coverage of behavioral and social factors alongside psychological and biobehavioral content. That focus signals interest in the full complexity of aging as it unfolds in real life: behavior change, social context, stress and resilience, cognition and emotion, health behaviors, and biological correlates that connect lived experience to health outcomes. The infrastructure supported by this FOA is intended to make those complex datasets more interoperable and more useful for the field by promoting coordination and collaboration, and by enabling innovation in how these studies work together.

Eligibility is broad and includes many U.S.-based organizational types that commonly participate in NIH funding. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories as listed); for-profit organizations other than small businesses; small businesses; and other organizations that meet NIH eligibility requirements. The FOA also explicitly notes additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American Tribal Governments other than federally recognized, and U.S. territories or possessions.

Foreign eligibility is restricted in a way that is common for NIH opportunities focused on U.S. infrastructure. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization. Non-domestic components of U.S. organizations are also not eligible to apply. However, "foreign components" as defined in the NIH Grants Policy Statement are allowed, meaning a U.S. applicant may include certain well-justified activities performed outside the U.S. when permitted under NIH policy, even though the applicant institution itself must be domestic.

Administratively, the opportunity is categorized under the Health funding activity area and is associated with CFDA number 93.866. The original closing date listed is July 1, 2022, and the FOA creation date is December 20, 2021. The source information provided does not specify an award ceiling or the expected number of awards, so those details would normally be confirmed by reviewing the full FOA text and any related NIH notices. Overall, the grant is best understood as support for a coordinating, resource-building hub or network that strengthens the connective tissue across major longitudinal behavioral and social studies of aging, rather than funding a single hypothesis-driven study or any clinical trial activity.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2021-12-20.
  • Applicants must submit their applications by 2022-07-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 23 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH RFA-AG-23-003 (U24, Clinical Trial Not Allowed)

What is the title and identifier of this NIH funding opportunity?

The opportunity is NIH RFA-AG-23-003, titled "Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)."

What is the main purpose of this funding opportunity?

The purpose is to build and operate a coordinated set of shared resources that make it easier for the research community to work across multiple long-running studies of aging that have unusually rich, detailed measurement (deep phenotyping) in psychological, behavioral, social, and biobehavioral domains.

Is this opportunity intended to fund a clinical trial?

No. The FOA explicitly indicates "Clinical Trial Not Allowed." The overall aim is not to run a clinical trial, but to create and run shared infrastructure that supports coordination and collaboration across existing longitudinal studies of aging.

What funding mechanism does NIH use for this opportunity?

NIH uses a cooperative agreement mechanism (U24). This means the awardee is expected to work in close partnership with NIH staff, with substantial involvement typical for this type of funding.

What is meant by a "cooperative agreement" (U24) in practical terms?

In practical terms, a U24 cooperative agreement typically involves active collaboration with NIH staff during project execution. The funded project is expected to operate as a coordinated resource effort rather than a fully independent, investigator-only activity.

What is the central structure being created under this FOA?

The FOA centers on creating a Resource Development Network. This network is intended to serve as shared infrastructure that helps separate longitudinal cohorts and studies align with one another, communicate, and collaborate more efficiently.

Why does NIH want a Resource Development Network for these studies?

Longitudinal aging studies often collect overlapping but not identical measures over many years. That makes cross-study comparisons and pooled analyses difficult even when scientific questions are similar. NIH is seeking an effort that actively supports coordination so investigators can more readily harmonize measures, compare findings, innovate on methods, and generate stronger, more generalizable insights about aging.

What kinds of studies are the focus of this opportunity?

The focus is on studies of aging that are both longitudinal (repeated measurement over time) and deeply phenotyped (rich, detailed measurement), particularly in psychological, behavioral, social, and biobehavioral domains.

What does "deeply phenotyped" imply in this context?

Within the information provided, "deep phenotyping" refers to unusually rich, detailed measurement across psychological, behavioral, social, and biobehavioral domains, capturing the complexity of aging and its correlates over time.

What types of research content or domains are emphasized?

The FOA emphasizes broad coverage of behavioral and social factors alongside psychological and biobehavioral content, including areas such as behavior change, social context, stress and resilience, cognition and emotion, health behaviors, and biological correlates that connect lived experience to health outcomes.

Is the goal to create new datasets, or to make existing studies work better together?

Based on the description provided, the emphasis is on building resources that promote coordination and collaboration across multiple existing long-running studies, making complex datasets more interoperable and more useful for harmonization, comparison, pooled analyses, and methodological innovation.

What are examples of activities this infrastructure is intended to enable?

The infrastructure is intended to help investigators harmonize measures across studies, compare findings across cohorts, innovate on cross-study methods, and support collaboration so that results can be more robust and generalizable than those from any single study alone.

Who is eligible to apply?

Eligibility is broad and includes many U.S.-based organizational types commonly eligible for NIH funding, including various government entities, educational institutions, tribal governments and organizations, nonprofits, for-profits, small businesses, and other organizations meeting NIH eligibility requirements.

Which government entities are eligible applicants?

Eligible government applicants include state governments; county governments; city or township governments; special district governments; independent school districts; and eligible federal agencies (as explicitly noted among additional eligible applicant types).

Are institutions of higher education eligible?

Yes. Public and state-controlled institutions of higher education and private institutions of higher education are listed as eligible applicants.

Are nonprofit organizations eligible?

Yes. Nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status are listed as eligible, with the provided text noting exclusions related to institutions of higher education in those nonprofit categories as listed.

Are for-profit organizations or small businesses eligible?

Yes. For-profit organizations other than small businesses are eligible, and small businesses are also eligible.

Are tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments are eligible. Native American tribal organizations other than federally recognized tribal governments are also listed as eligible, and the additional eligibility notes also include Indian/Native American Tribal Governments other than federally recognized.

Are U.S. territories or possessions eligible to apply?

Yes. U.S. territories or possessions are explicitly noted among additional eligible applicant types.

Are minority-serving institutions specifically mentioned as eligible?

Yes. The FOA explicitly notes additional eligible types including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, and TCCUs.

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly mentioned among additional eligible applicant types.

Can non-U.S. (foreign) institutions apply as the applicant organization?

No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization.

Can a non-domestic component of a U.S. organization apply?

No. Non-domestic components of U.S. organizations are also not eligible to apply.

Are any activities outside the U.S. allowed under this FOA?

Yes, in a limited sense. "Foreign components" (as defined in the NIH Grants Policy Statement) are allowed. That means a U.S. applicant may include certain well-justified activities performed outside the U.S. when permitted under NIH policy, even though the applicant institution must be domestic.

What is the associated CFDA number and funding activity area?

The opportunity is associated with CFDA number 93.866 and is categorized under the Health funding activity area.

What are the key dates provided for this opportunity?

The FOA creation date is December 20, 2021, and the original closing date listed is July 1, 2022.

Does the provided information include an award ceiling or the expected number of awards?

No. The source information provided does not specify an award ceiling or the expected number of awards. Those details would normally be confirmed by reviewing the full FOA text and any related NIH notices.

How should applicants think about the overall "shape" of the project NIH wants to support?

This grant is best understood as support for a coordinating, resource-building hub or network that strengthens connectivity across major longitudinal behavioral and social studies of aging, rather than funding a single hypothesis-driven study or any clinical trial activity.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: FY 2022 Cooperative Endangered Species Conservation Fund (CESCF) Traditional Conservation Grants Program (Service Legacy Region 4)

Previous opportunity: Cooperative Agreement for Affiliated Partner with Great Basin Cooperative Ecosystems Studies Unit

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 23 003

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 23 003) also looked into and applied for these:

Funding Opportunity
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) Apply for PAR 22 077

Funding Number: PAR 22 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 22 093

Funding Number: PAR 22 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) Apply for PAR 22 094

Funding Number: PAR 22 094
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) Apply for RFA MH 22 135

Funding Number: RFA MH 22 135
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) Apply for RFA MH 22 136

Funding Number: RFA MH 22 136
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) Apply for RFA AI 21 079

Funding Number: RFA AI 21 079
Agency: National Institutes of Health
Category: Health
Funding Amount: $900,000
Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 009

Funding Number: RFA AG 23 009
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 22 088

Funding Number: PAR 22 088
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed) Apply for PAR 21 363

Funding Number: PAR 21 363
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) Apply for RFA MD 22 003

Funding Number: RFA MD 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) Apply for RFA AG 23 008

Funding Number: RFA AG 23 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional) Apply for RFA AG 23 006

Funding Number: RFA AG 23 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $425,000
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 032

Funding Number: RFA NS 22 032
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) Apply for RFA NS 22 033

Funding Number: RFA NS 22 033
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) Apply for RFA HL 23 003

Funding Number: RFA HL 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 004

Funding Number: RFA NS 22 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $600,000
Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 001

Funding Number: RFA AI 22 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional) Apply for PAR 22 362

Funding Number: PAR 22 362
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 22 081

Funding Number: PAR 22 081
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 22 080

Funding Number: PAR 22 080
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: